Cargando...

Pathogen-like Nanoassemblies of Covalently Linked TLR Agonists Enhance CD8 and NK Cell-Mediated Antitumor Immunity

[Image: see text] Therapies based on Toll Like Receptor agonists (TLRa) are emerging as a promising modality for cancer immunotherapy to recruit antitumor T-cells in unresponsive immunologically “cold” tumors. Often, combinations of agonists are employed to synergistically enhance efficacy. However,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:ACS Cent Sci
Autores principales: Manna, Saikat, Maiti, Sampa, Shen, Jingjing, Du, Wenjun, Esser-Kahn, Aaron P.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Chemical Society 2020
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7706081/
https://ncbi.nlm.nih.gov/pubmed/33274283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acscentsci.0c01001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!